Social Adaptation in Long Term Survivors of Blood and Marrow Transplantation

NCT01165788 | Completed DMC

• 2 other identifiers: BMT216SU-07092010-6496
• Study Type: observational
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

1. 1.To explore specific aspects of social adaptation such as social connectedness, occupational outcomes and family relationships in lymphoma patients after autologous blood or marrow transplantation (BMT).
2. 2.To investigate how social adaptation varies with time lapsed since BMT and with the life stage as determined by patient?s age. Understanding both the positive and negative aspects of cancer and cancer therapy leads to opportunities to promote adaptive strategies.

Conditions

Social Adaptation

Keywords

Blood and Marrow Transplant (BMT)

Outcome Measures

Primary Outcomes (2)

• Specific aspects of social adaptation, such as social connectedness, occupational outcomes and family relationships in lymphoma patients after autologous blood or marrow transplantation (BMT)

  1 year

• Social adaptation variation with time lapsed since BMT and with the life stage as determined by patient's age

  1 year

Study Arms (1)

autologous BMT recipients

Lymphoma patients who received an autologous BMT as adults

Procedure: Semi structured personal interview

Interventions

Semi structured personal interview PROCEDURE

A trained research assistant will conduct in-person, in-depth semi-structured interviews at a location of the participants choosing. Participants will be asked to discuss their experiences with cancer, focusing especially on how their cancer affected their (1) work/education (2) relationships with their family (spouse, children, parents, siblings and other relatives) (3) their other social relationships

autologous BMT recipients

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Subjects will be identified from the comprehensive database of the Blood and Marrow Transplant Division of Stanford Hospitals \& Clinics. We will target lymphoma patients who received an autologous BMT as adults (18 years or older). We estimate there are \~580 surviving who are between 2 and 22 years post-BMT.

You may qualify if:

• Lymphoma patients treated with blood and marrow transplantation at Stanford University Medical Center
• Age \> 18 years at the time of transplant
• English speaking
• Willingness to sign a written informed consent document

Sponsors & Collaborators

• Stanford University: lead

Study Sites (1)

Stanford University School of Medicine

Stanford, California, 94305, United States

Location

MeSH Terms

Conditions

Social Adjustment

Condition Hierarchy (Ancestors)

Social Behavior; Behavior

Study Officials

• Karen Cook

  Stanford University

  PRINCIPAL INVESTIGATOR

• Kate Tierney

  Stanford University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: FAMILY BASED
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 16, 2010
• First Posted: July 20, 2010
• Study Start: November 1, 2009
• Primary Completion: November 1, 2010
• Study Completion: June 28, 2017
• Last Updated: December 2, 2017

Record last verified: 2017-11

Locations

US (1)